Globus Medical (GMED) — Quality & forensics
As of 2026-11-10 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 53
- Quality 65
- Growth 54
- Balance sheet 85
- Cash quality 53
- Capital allocation 61
- Momentum 37
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the GMED chart & overview · the earnings record
FAQ · from the current data · as of 2026-11-10
Quick answers
What is Globus Medical's Closelooknet quality reading?
The composite reads 60/100 across 7 modules, as of 2026-11-10: valuation 53, quality 65, growth 54, balance sheet 85, cash quality 53, capital allocation 61, momentum 37. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Globus Medical's Altman Z-Score?
10.37, which sits in the safe zone (above 2.99) as of 2026-11-10. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Globus Medical's Piotroski F-Score?
8 of 8, as of 2026-11-10. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Globus Medical's Beneish M-Score indicate?
-2.50 — below the −1.78 manipulation-risk threshold, as of 2026-11-10. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- RACE Ferrari NV
- LLY Eli Lilly and Company
- REGN Regeneron Pharmaceuticals Inc
- DXCM DexCom Inc
- HDB HDFC Bank Limited ADR
- TOST Toast Inc
- ONON On Holding Ltd
- VRSK Verisk Analytics Inc
- FAST Fastenal Company
- IDXX IDEXX Laboratories Inc
- ZEAL.CO Zealand Pharma A/S
- ERJ Embraer S.A.
- SECT-B.ST Sectra AB (publ)industry
- SNN Smith & Nephew SNATS Incindustry
- SOON.SW Sonova H Agindustry
- GKOS Glaukos Corpindustry
- SYK Stryker Corporationindustry
- GEHC GE HealthCare Technologies Inc.industry
- ENOV Enovis Corpindustry
- MED.SW Medartis Holding AGindustry